In the study of MALAT1 and miR-22-3p, it was also found that MALAT1 regulates ZFP91 through sponge miR-22-3p to enhance GC cells’ resistance to oxaliplatin (OXA) [121]. Here, MALAT1 is linked to gastric cancer.